" investors that aren't in for the long run are going to pull out ASAP."That's a no brainer for many savvy investors. Too many shades of grey in this long running saga.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025